News releases from the National Institutes of Health (NIH)
Updated: 19 weeks 4 days ago
Researchers found that 48 of 50 children retained their replenished immune system function two to three years later and did not require additional treatments for ADA-SCID.
NIH leaders emphasize the importance of patient voices in addiction medication development.
NIH-funded advance could alert physicians to increased need for fetal monitoring, early delivery.
The chronic lung disease can reduce quality of life, contributes to considerable emotional and financial stress, and is a major contributing factor to missed time from school and work.
NIH BRAIN Initiative-funded study opens the door to correlating deep brain activity and behavior.
The unique combination of compounds and drugs greatly improved stem cell survival and reduced cell culture stress.
Effort will foster community-engagement research in communities which have been hit hardest by the pandemic.
NIH-funded study suggests an anticancer drug could prevent bleeding into the brain.
NIH-funded study in mice suggests lymphatic boost could help reduce amyloid buildup.
NIH-supported trial will test dalbavancin in hospitalized adults.
NIH-funded research project develops app to track eye movements in response to videos.
Network will conduct pediatric asthma research in low-income urban settings.
Enrollment begins at NIH Clinical Center.
The findings are published around the 35th anniversary of the nuclear disaster.
Study adds to a growing body of evidence that prenatal exposure to marijuana may be associated with poor birth outcomes.
Patients with acute respiratory failure may now enroll in NIH-sponsored trial.
Study is part of an effort to speed development of the most promising treatments and vaccine candidates.
Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.
MK-4482 shows potential to prevent and treat SARS-CoV-2 infection.
New RADx-UP research effort combines testing and safety measures in underserved populations.